The predictive value of coexisting BRAFV600E and TERT promoter mutations on poor outcomes and high tumour aggressiveness in papillary thyroid carcinoma: A systematic review and meta-analysis.
Clinical endocrinology | 2021-05-01 | PMID 32816325
Chen Bojie, Shi Yuan, Xu Yanan and 1 more
